DR Congo receives first batch of Ebola vaccines as outbreak accelerates

The Democratic Republic of Congo has received its first consignment of Ervebo vaccine doses as officials intensify efforts to control the spread of Ebola in Kinshasa. The 16,000-plus doses mark the start of a larger vaccination campaign, with 70,000 additional doses allocated for deployment across the capital.

Health experts have raised concerns about the trajectory of the outbreak, warning that cases could multiply exponentially without swift intervention. The arrival of vaccine supplies underscores the urgency of immunization efforts aimed at containing the virus before transmission accelerates further.

Ervebo, developed by Merck, has demonstrated effectiveness in preventing Ebola infection and has been deployed in previous outbreaks across Central Africa. The staggered delivery schedule reflects the logistical challenges of deploying medical countermeasures in response to the fast-moving epidemic.

Authorities in Kinshasa are coordinating vaccination campaigns with international health partners to ensure equitable distribution and rapid administration of doses to priority populations, including healthcare workers and close contacts of confirmed cases. Officials have not disclosed specific timelines for administering the remaining vaccine doses, but emphasized that speed remains critical to suppressing community transmission.